NEW YORK CITY, NY / ACCESS Newswire / February 19, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies ...

NEW YORK, NY / ACCESS Newswire / February 18, 2025 / If you suffered a loss on your GSK plc (NYSE:GSK) investment and want to learn about a ...

CEO, Colin Waggett, says the former House of Fraser on Oxford Street is a great and improving, catchment area ...

GSK plc (LSE/NYSE: GSK) today announced that the US Food and Drug Administration (FDA) has approved PENMENVY (Meningococcal Groups A, B, C, W, and Y Vaccine) for use in individuals aged 10 through 25 ...

THE boss of an electric car-charging firm that last week received £55million from taxpayers has admitted it broke the law by ...

London stocks were still a touch higher by midday on Wednesday as investors continued to mull the impact of Trump’s trade war, with GSK surging after it lifted its long-term sales guidance and ...

GSK shares added ~6% in London trading on Wednesday after the British drugmaker lifted its 2031 outlook and announced a new share buyback program alongside better-than-expected earnings for Q4 2025.

and GSK has to prove its drug development pipeline is packed with new blockbuster treatments. “An increased dividend and the launch of a first major share buyback in more than a decade suggest ...

The Ozempic craze remains in place, and Nordisk is reaping the benefits. GSK is powering ahead and is one of the best performers on the FTSE 100 this morning. Its earnings reports ticked all of ...

GSK said it expects core operating profits to rise by between 6% and 8% this year, with turnover said to lift by between 3% and 5%. It said it expects further growth to be boosted by its strong ...

Pharmaceutical giant GlaxoSmithKline (GSK ... It said it expects further growth to be boosted by its strong pipeline of new drugs, with 71 specialty medicines and vaccines now in clinical development.